Review



il 36β  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems il 36β
    Il 36β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36β/product/R&D Systems
    Average 93 stars, based on 2 article reviews
    il 36β - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems il 36β
    Il 36β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 36β/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    il 36β - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant mouse il 36β
    Recombinant Mouse Il 36β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse il 36β/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant mouse il 36β - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    92
    R&D Systems daro1118111 15 rmil 36β r d systems
    Daro1118111 15 Rmil 36β R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/daro1118111 15 rmil 36β r d systems/product/R&D Systems
    Average 92 stars, based on 1 article reviews
    daro1118111 15 rmil 36β r d systems - by Bioz Stars, 2026-05
    92/100 stars
      Buy from Supplier

    93
    R&D Systems rhil 36β il 1f8
    Rhil 36β Il 1f8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rhil 36β il 1f8/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    rhil 36β il 1f8 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    R&D Systems human il 36β protein
    Figure 1. <t>IL-36β</t> is overexpressed on epidermal keratinocytes in lesional skin of atopic dermatitis (AD). (A,B) IL-36β staining in healthy skin and AD lesional skin (n = 10, respectively). Representative images of IL-36β staining in AD skin (A) and in healthy skin (B) are shown (original magnification ×400). Arrows point to representative keratinocytes with the nuclear staining. (C) Double staining of IL-36β (red) and cytokeratin (brown) in AD lesional skin (n = 10). Representative image is shown. Arrows point to representative keratinocytes with nuclear IL-36β staining and cytokeratin staining. (D) IL-36β staining intensity is shown. The measured values from individual patients are plotted by dots. * p < 0.05.
    Human Il 36β Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human il 36β protein/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    human il 36β protein - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. IL-36β is overexpressed on epidermal keratinocytes in lesional skin of atopic dermatitis (AD). (A,B) IL-36β staining in healthy skin and AD lesional skin (n = 10, respectively). Representative images of IL-36β staining in AD skin (A) and in healthy skin (B) are shown (original magnification ×400). Arrows point to representative keratinocytes with the nuclear staining. (C) Double staining of IL-36β (red) and cytokeratin (brown) in AD lesional skin (n = 10). Representative image is shown. Arrows point to representative keratinocytes with nuclear IL-36β staining and cytokeratin staining. (D) IL-36β staining intensity is shown. The measured values from individual patients are plotted by dots. * p < 0.05.

    Journal: International journal of molecular sciences

    Article Title: Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis.

    doi: 10.3390/ijms241311104

    Figure Lengend Snippet: Figure 1. IL-36β is overexpressed on epidermal keratinocytes in lesional skin of atopic dermatitis (AD). (A,B) IL-36β staining in healthy skin and AD lesional skin (n = 10, respectively). Representative images of IL-36β staining in AD skin (A) and in healthy skin (B) are shown (original magnification ×400). Arrows point to representative keratinocytes with the nuclear staining. (C) Double staining of IL-36β (red) and cytokeratin (brown) in AD lesional skin (n = 10). Representative image is shown. Arrows point to representative keratinocytes with nuclear IL-36β staining and cytokeratin staining. (D) IL-36β staining intensity is shown. The measured values from individual patients are plotted by dots. * p < 0.05.

    Article Snippet: Simultaneously, the recombinant human IL-36β protein (R&D systems, Minneapolis, MN, USA) were added, and the cells were incubated at 37 ◦C and 5% CO2.

    Techniques: Staining, Double Staining

    Figure 2. Serum IL-36β levels are not elevated in patients with atopic dermatitis (AD) but decreased by dupilumab. (A) Serum IL-36β levels in AD patients (n = 36) and healthy control (n = 15). (B) Serum IL-36β levels in severe AD patients (n = 16) and mild/moderate AD patients (n = 20). (C) Serum IL-36β levels in AD patients (n = 7) before and after dupilumab treatment. The measured values from individual patients are plotted by dots. Bars represent the median. * p < 0.05.

    Journal: International journal of molecular sciences

    Article Title: Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis.

    doi: 10.3390/ijms241311104

    Figure Lengend Snippet: Figure 2. Serum IL-36β levels are not elevated in patients with atopic dermatitis (AD) but decreased by dupilumab. (A) Serum IL-36β levels in AD patients (n = 36) and healthy control (n = 15). (B) Serum IL-36β levels in severe AD patients (n = 16) and mild/moderate AD patients (n = 20). (C) Serum IL-36β levels in AD patients (n = 7) before and after dupilumab treatment. The measured values from individual patients are plotted by dots. Bars represent the median. * p < 0.05.

    Article Snippet: Simultaneously, the recombinant human IL-36β protein (R&D systems, Minneapolis, MN, USA) were added, and the cells were incubated at 37 ◦C and 5% CO2.

    Techniques: Control

    Figure 3. IL-36β promotes vascular endothelial growth factor (VEGF)-A and placental growth factor (PlGF) mRNA expression in HaCaT cells. (A,B) HaCaT were cultured with recombinant IL-36β (0, 100 ng/mL) for 24 h. Messenger RNA levels of the indicated Th2 cytokines and chemokines (A) and angiogenic factors (B) were determined by quantitative RT-PCR. One representative result from three independent experiments. The measured values from individual samples are plotted by dots. Bars represent the median. (n = 4–6). * p < 0.05.

    Journal: International journal of molecular sciences

    Article Title: Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis.

    doi: 10.3390/ijms241311104

    Figure Lengend Snippet: Figure 3. IL-36β promotes vascular endothelial growth factor (VEGF)-A and placental growth factor (PlGF) mRNA expression in HaCaT cells. (A,B) HaCaT were cultured with recombinant IL-36β (0, 100 ng/mL) for 24 h. Messenger RNA levels of the indicated Th2 cytokines and chemokines (A) and angiogenic factors (B) were determined by quantitative RT-PCR. One representative result from three independent experiments. The measured values from individual samples are plotted by dots. Bars represent the median. (n = 4–6). * p < 0.05.

    Article Snippet: Simultaneously, the recombinant human IL-36β protein (R&D systems, Minneapolis, MN, USA) were added, and the cells were incubated at 37 ◦C and 5% CO2.

    Techniques: Expressing, Cell Culture, Recombinant, Quantitative RT-PCR

    Figure 4. IL-36β enhances vascular endothelial growth factor (VEGF)-A protein production via extracellular signal-regulated kinase (ERK)-1/2 pathway from HaCaT cells. (A) HaCaT cells were cultured with recombinant IL-36β (0, 50, 100 ng/mL) for 24 h. Supernatant IL-36β levels were evaluated by enzyme-linked immunosorbent assay. (B) HaCaT cells were cultured with recombinant IL-36β (100 ng/mL) for 24 h in the absence or after preincubation with U0126 (20 nM), LY294002 (20 nM), SB203580 (20 nM), or sc-514 (40 nM). Supernatant IL-36β levels were evaluated by enzyme- linked immunosorbent assay. One representative result from three independent experiments. The measured values from individual samples are plotted by dots. Bars represent the median. (n = 6). * p < 0.05. ** p < 0.01.

    Journal: International journal of molecular sciences

    Article Title: Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis.

    doi: 10.3390/ijms241311104

    Figure Lengend Snippet: Figure 4. IL-36β enhances vascular endothelial growth factor (VEGF)-A protein production via extracellular signal-regulated kinase (ERK)-1/2 pathway from HaCaT cells. (A) HaCaT cells were cultured with recombinant IL-36β (0, 50, 100 ng/mL) for 24 h. Supernatant IL-36β levels were evaluated by enzyme-linked immunosorbent assay. (B) HaCaT cells were cultured with recombinant IL-36β (100 ng/mL) for 24 h in the absence or after preincubation with U0126 (20 nM), LY294002 (20 nM), SB203580 (20 nM), or sc-514 (40 nM). Supernatant IL-36β levels were evaluated by enzyme- linked immunosorbent assay. One representative result from three independent experiments. The measured values from individual samples are plotted by dots. Bars represent the median. (n = 6). * p < 0.05. ** p < 0.01.

    Article Snippet: Simultaneously, the recombinant human IL-36β protein (R&D systems, Minneapolis, MN, USA) were added, and the cells were incubated at 37 ◦C and 5% CO2.

    Techniques: Cell Culture, Recombinant, Enzyme-linked Immunosorbent Assay

    Figure 5. IL-36β staining intensity in epidermal keratinocytes is correlated with the number of dermal vessels in lesional skin with atopic dermatitis (AD). (A–D) Vascular endothelial growth factor (VEGF)-A (A,B) and plancental growth factor (PlGF) (C,D) staining in healthy skin and AD lesional skin (n = 10, respectively). Representative images of VEGF-A and PlGF staining in AD skin (A,C), and in healthy skin (B,D) are shown (original magnification ×400). Arrows point to representative keratinocytes with the nuclear staining. (E,F) Double staining of IL-36β (red) and CD34 (brown) in AD lesional skin (n = 10). Representative images of AD skin with relatively few dermal vessels (E) and with relatively abundant dermal vessels (F) are shown (original magnification ×200). (G) The correlation between IL-36β staining intensity and the number of CD34-positive dermal vessels (n = 10). The measured values from individual patients are plotted by dots.

    Journal: International journal of molecular sciences

    Article Title: Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis.

    doi: 10.3390/ijms241311104

    Figure Lengend Snippet: Figure 5. IL-36β staining intensity in epidermal keratinocytes is correlated with the number of dermal vessels in lesional skin with atopic dermatitis (AD). (A–D) Vascular endothelial growth factor (VEGF)-A (A,B) and plancental growth factor (PlGF) (C,D) staining in healthy skin and AD lesional skin (n = 10, respectively). Representative images of VEGF-A and PlGF staining in AD skin (A,C), and in healthy skin (B,D) are shown (original magnification ×400). Arrows point to representative keratinocytes with the nuclear staining. (E,F) Double staining of IL-36β (red) and CD34 (brown) in AD lesional skin (n = 10). Representative images of AD skin with relatively few dermal vessels (E) and with relatively abundant dermal vessels (F) are shown (original magnification ×200). (G) The correlation between IL-36β staining intensity and the number of CD34-positive dermal vessels (n = 10). The measured values from individual patients are plotted by dots.

    Article Snippet: Simultaneously, the recombinant human IL-36β protein (R&D systems, Minneapolis, MN, USA) were added, and the cells were incubated at 37 ◦C and 5% CO2.

    Techniques: Staining, Double Staining